A visionary company
Transforming ophthalmic care with sustained release therapies
Hydrogel Technology
A platform Engineered for Ocular Innovation
Focused on the future
Developing therapies to enhance the current standard of care
Driven by a vision
Pioneering a new era of drug delivery in ophthalmology
Ocular Therapeutix is a biopharmaceutical company aspiring to be a leader in ophthalmology by leveraging its proprietary hydrogel technology to develop transformational drug products that enhance the patient and provider experience.
Featured Press Release
FDA Accepts DEXTENZA NDA Submission
Action Date: Dec. 28, 2018